Gene Myers, group leader at the Howard Hughes Medical Institute’s Janelia Farm Research Campus in Ashburn, Va., has joined the scientific advisory board of next-generation sequencing developer Helicos BioSciences. Myers has played a role in the development of Blast and Celera Genomics’ whole-genome sequence assembler and is currently focused on the development of algorithms and software for image analysis.
“As Helicos continues its rapid growth, we recognize the need to continue to build a bioinformatics capability designed to fully support our efforts,” said Stanley Lapidus, president and CEO of Helicos, in a statement.
Myers joined the scientific advisory board of 454 Life Sciences, a subsidiary of Curagen that is also developing new sequencing technology, in 2003 [BioInform 03-17-03].